A study for a 35 year old woman who takes Imuran, Lansoprazole, Pentasa, Prednisolone - from FDA reports

14 females aged 35 (±5) who take the same drugs are studied. This is a personalized study for a 35 year old female patient who has Crohns, Hiatus Hernia, Crohns Disease. The study is created by eHealthMe based on reports from FDA.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).

On Aug, 20, 2018

14 females aged 35 (±5) who take Imuran, Lansoprazole, Pentasa, Prednisolone are studied.

Number of reports submitted per year:

Imuran, Lansoprazole, Pentasa, Prednisolone for a 35-year old woman.

Information of the patient in this study:

  • Age: 35
  • Gender: female
  • Conditions: Crohns, Hiatus Hernia, Crohns Disease
  • Drugs taken:
    • Prednisolone (prednisolone)
    • Lansoprazole (lansoprazole)
    • Pentasa (mesalamine)
    • Imuran (azathioprine)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Elevated Temperature(high temperature): 0 (0% of females aged 35 (±5) who take the drugs)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common drug interactions over time

< 1 month:
  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Skin ulcer
  3. Therapeutic response decreased (less preventive response)
  4. Drug level increased
  5. Hyperkeratosis (thickening of the outer layer of the skin)
1 - 6 months:
  1. Vasculitis (inflammation of a blood vessel or blood vessels)
  2. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  3. Skin ulcer
  4. Therapeutic response decreased (less preventive response)
6 - 12 months:
1 - 2 years:
  1. Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
  2. Gastrointestinal perforation (hole in the digestive tract)
  3. Anaemia postoperative
2 - 5 years:
5 - 10 years:
10+ years:
not specified:
  1. Therapeutic response decreased (less preventive response)
  2. Vasculitis (inflammation of a blood vessel or blood vessels)
  3. Skin ulcer
  4. Joint pain
  5. Nausea (feeling of having an urge to vomit)

Top conditions involved for these people *:

  1. Muscle Tightness : 2 people, 14.29%
  2. Gastritis (inflammation of stomach): 2 people, 14.29%
  3. Vitamin Supplementation : 1 person, 7.14%
  4. Preventive Health Care : 1 person, 7.14%
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 7.14%

Top co-used drugs for these people *:

  1. Remicade (5 people, 35.71%)
  2. Cimzia (4 people, 28.57%)
  3. Prograf (3 people, 21.43%)
  4. Cefazolin Sodium (2 people, 14.29%)
  5. Entocort Ec (2 people, 14.29%)

* Some reports may have incomplete information.

FDA reports used in this study

You are not alone:

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Related publications that referenced our studies

Recent updates

General studies

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.